Overview (18 Sep 2026)
Cohance Lifesciences Ltd
COHANCE
INE03QK01018

Pharmaceuticals
Result was last declared on 12 May 2026
-1.95

Prev. Close
Previous Close
439.95
Current Close
438
Current High
446.65
Current Low
429.25
52 Week High
932.65
52 Week Low
267.85
Resistance 1
446.69
Resistance 2
455.37
Support 1
429.29
Support 2
411.89
Std Deviation
2.74%
DMA 200
421.09
DMA 50
443.59
DMA 20
449.03
Fundamentals and Ratios
Standalone
Trailing EPS
5.98
Forwad EPS
2.01
Trailing P/E
73.24
Forward P/E
217.55
PEG Ratio
-3.28
Mkt. Cap (Cr)
Market Cap (Cr)
16756.44
Total Debt(Cr)
Tot. Debt(Cr)
169.67
Reserve (Cr)
3873.03
Book Value
54.53
P/BV Ratio
8.03
ROCE(%)
5.00
ROE
6.00
Consolidated
Trailing EPS
4.69
Forwad EPS
0.85
Trailing P/E
93.39
Forward P/E
513.28
PEG Ratio
-3.99
Mkt. Cap (Cr)
Market Cap (Cr)
16756.44
Total Debt(Cr)
Tot. Debt(Cr)
400.49
Reserve (Cr)
3873.03
Book Value
102.23
P/BV Ratio
4.28
ROCE(%)
2.92
ROE
1.5000

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue422.26567.55481.58497.79483.582030.5
Other Income12.25-0.796.1226.3013.1044.73
Total Income434.51566.76487.70524.09496.682075.23
Interest6.745.175.255.246.8022.46
Expenditure-477.38-493.81-417.41-403.37-417.54-1732.13
PBDT0.000.000.000.000.000.00
Depreciation-49.54-37.66-33.36-31.20-31.36-133.58
PBT-42.8756.4465.43120.7271.04313.63
Tax-2.32-21.88-18.14-26.43-18.47-84.92
Equity38.2638.260.000.0038.2638.26
OPM-9.879.9613.5924.2514.3015.11
Net Profit-45.1934.5647.2994.2952.57228.71
NPM-10.46.19.8218.9410.5811.02
EPS-0.630.91.242.461.385.98
Consolidated
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue422.26619.12544.55555.57549.312268.55
Other Income12.25-1.846.1615.6014.1734.09
Total Income434.51617.28550.71571.17563.482302.64
Interest6.749.190.008.7610.1837.24
Expenditure-477.38-580.86-505.25-487.40-492.62-2066.13
PBDT0.000.000.000.000.000.00
Depreciation-49.54-51.230.00-44.02-45.14-187.33
PBT-42.8719.9140.6083.7762.76207.04
Tax-2.32-11.60-11.58-17.38-16.36-56.92
Equity38.2638.260.000.0038.2638.26
OPM-9.873.237.3714.6711.148.99
Net Profit-45.198.3129.0266.3946.4150.12
NPM-10.41.355.2711.628.236.52
EPS-0.630.5101.941.284.69
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings